A PHASE I STUDY OF HUMAN PLACENTAL HEMATOPOIETIC STEM CELL DERIVED NATURAL KILLER CELLS (CYNK-001) IN MULTIPLE MYELOMA PATIENTS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT IN THE FRONT-LINE SETTING
Categories (click each to see list of all clinical trials associated with that category): Myeloma/Plasma Cell Dyscrasia
Current Status: Open to accrual
Phase: I
Principal Investigator: Holstein, Sarah
Contact Information:
Amberley Proctor
+1 402-836-9171
amberley.proctor@unmc.edu
Eligibility: https://www.clinicaltrials.gov/ct2/show/NCT04309084?cond=NCT04309084&draw=2&rank=1#eligibility
Summary